⌘K
Loading ticker…
As of 2026-08-24, Champions Oncology, Inc. (CSBR) has a 3-month relative strength percentile of 22 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 41. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.3%, relative volume 0.79×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
CSBR is in a stage 4 downtrend, week 4. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -13.6% / -19.4%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
CSBR is held by 2 ETFs as of Apr 2026. Top owner: DCOR at 0.00% weight, $5K notional.
Held by 5 ETFs · $2M across latest filings · largest weight 0.01% (IWC).
Top 2 by value, from SEC N-PORT-P filings dated Apr 2026.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CSBR Jan avg: 7.13% median: 4.59% win: 75% σ: 15.46% n: 4 2022-04-12 → 2026-07-31 | CSBR Feb avg: -2.58% median: -2.46% win: 50% σ: 13.34% n: 4 2022-04-12 → 2026-07-31 | CSBR Mar avg: -12.38% median: -14.56% win: 0% σ: 6.12% n: 4 2022-04-12 → 2026-07-31 | CSBR Apr avg: 1.12% median: -1.02% win: 40% σ: 14.35% n: 5 2022-04-12 → 2026-07-31 | CSBR May avg: -4.87% median: -3.65% win: 20% σ: 8.63% n: 5 2022-04-12 → 2026-07-31 | CSBR Jun avg: 15.16% median: 14.13% win: 100% σ: 8.72% n: 5 2022-04-12 → 2026-07-31 | CSBR Jul avg: -4.89% median: -7.35% win: 40% σ: 9.72% n: 5 2022-04-12 → 2026-07-31 | CSBR Aug avg: -2.27% median: -2.39% win: 50% σ: 9.13% n: 4 2022-04-12 → 2026-07-31 (current) | CSBR Sep avg: -0.68% median: -5.40% win: 25% σ: 10.77% n: 4 2022-04-12 → 2026-07-31 | CSBR Oct avg: -8.40% median: -9.77% win: 25% σ: 10.64% n: 4 2022-04-12 → 2026-07-31 | CSBR Nov avg: 1.24% median: -2.48% win: 25% σ: 9.82% n: 4 2022-04-12 → 2026-07-31 | CSBR Dec avg: 17.44% median: 7.39% win: 75% σ: 52.05% n: 4 2022-04-12 → 2026-07-31 |